CAROL VORENKAMP-COOPER: Open Payments
NPI 1669461992 · OWOSSO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$266 in 13 payments from 8 companies in 2025. Trend: 2023 $180 · 2024 $339 · 2025 $266
Food & beverage: $266
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $96 |
| Amgen Inc. | 3 | $58 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: CAPLYTA, OTEZLA, NEFFY, Ozempic, Auvelity, ELIQUIS, GVOKE HYPOPEN, SPRAVATO.
Industry payments across MI — which companies pay providers there.
